News from the International Congress of Parkinson’s Disease and Movement Disorders: SOD1 Aggregates Identified in Brains of Patients with Parkinson’s Disease

July 21, 2016

Researchers reported novel evidence that superoxide dismutase 1 aggregates were associated through Parkinson’s disease pathology.

Web Image

BERLIN — What began similar to an effort to determine what makes cells in the substantia nigra weak in Parkinson’s disease (PD) in the end led an international team of investigators to be the same superoxide dismutase-1 (SOD1) aggregates in station-mortem tissue from people with this PD.

As the aggregates are indifferent in degenerating motor neurons in amyotrophic lateral sclerosis (ALS), and reduce to extreme purity and strength is only the degenerating regions of the PD brain, the scientists afore~ they suspect the abnormal protein ability also play a role in brain lonely dwelling death in PD.

Ben Trist, a graduate student at the Brain and Mind Centre and Discipline of Biomedical Sciences at the University of Sydney in Australia, reported the findings here in June at the International Congress of Movement Disorders and Parkinson’s Disease.

Kay Double, PhD, fraternize professor at the University of Sydney and spend researcher on this work, told Neurology Today that this first sight began when she was studying dopamine-producing cells of the substantia nigra. “

They embrace a melanin pigment and melanin binds metals,” she explained. “There was every increase in iron and a wane in copper levels specifically within the degenerating brain regions in PD, and this modify in copper led us to mark that SOD1 might be involved.”

SOD1 is a elucidation antioxidant in the brain, and menial levels of copper can alter the functioning of SOD1.

She and her colleagues cast SOD1 in neurons in the substantia nigra. They construct normal SOD1 in soluble form, end antibody staining revealed the presence of aggregated SOD1.

“That raised a red banner,” she said. She knew that the pathways that persuade to SOD1 aggregation result in the death of motor neurons in the spinal small rope in ALS patients with an SOD1 mutation. “Abnormal SOD1 also plays a role in sporadic cases of ALS,” she reported.

Others had also reported that some patients with PD have a overthrow of motor neurons in the spinal small rope, while some ALS patients lose cells in the substantia nigra.”

Working by colleagues at the Florey Institute of Neuroscience and Mental Health in Melbourne and at the University of Bordeaux in France, the scientists conducted studies to describe the aggregates and to count their disposal throughout the PD brains and those of ordinary controls.

Using immunohistochemistry, they identified Lewy dead ~ pathology and SOD1-immunopositive protein aggregates in regions of significant neuronal loss in the PD brain, reported Dr. Double.

“The SOD1 protein sum up was significantly more abundant in degenerating regions of the PD brain (through more than a five-fold be augmented in substantia nigra, and more than 2.5-pen increase in the locus coeruleus) compared with non-degenerating PD brain regions or in have the direction of brains.

Like SOD1 pathology in ALS, these aggregates contained expressive amounts of SOD1, copper chaperone since SOD1 and ubiquitin, but not alpha-synuclein. A decisive isoelectric point shift in SOD1 was in addition observed in the PD, compared through control brain, the researchers said.

“No one had ever looked for SOD1 aggregates in PD. It conscientious slipped under the radar,” Dr. Double told Neurology Today. “We looked at the aggregate of SOD1 and the functioning of the protein. The enzymatic etc. of the protein is reduced. One of the reasons that SOD1 aggregates in ALS is for the reason that it is not binding copper.”

Dr. Double declared she suspects that the SOD1 pathology could own a role in the vulnerability of the substantia nigra in PD. “We take found a 60 percent loss of cauldron in neurons in the substantia nigra in PD, with equal rea~n it makes sense that part of the question with SOD1 in PD is that it is not cover adequate amounts of copper to make capable the enzyme to function normally.”

The researchers furthermore had access to two brains from vulgar herd with a pathological form of preclinical PD goal no clinical disease. An intermediate reckon of SOD1 aggregates were found in these intellectual faculties, suggesting that the formation of the aggregates occurs excessively early in the disease process.

If the pathology is similar to what is seen in ALS, Dr. Double related, it is possible that the couple diseases could respond to the similar treatment.

ALS researcher Jeffrey Rothstein, MD, professor of neurology and neuroscience and monitor of the Brain Science Institute at Johns Hopkins University, before-mentioned that when aggregates form, they be possible to trap lots of other cytosolic protein in them. Since SOD1 is a excessively highly abundant cytosolic protein — 1 percent of every part of body protein is SOD1 — its not extraordinary that it could “decorate” these inclusions.”

Dr. Rothstein agrees that the verdict of the aggregates call for “superadded experiments aimed at reducing SOD1 to take care if it has any meaningful pathophysiological changes.”

“This is extremely pleasing,” said Robert H. Brown, Jr., MD, PhD, chair of the department of neurology at UMass Medical School. “There is a augmenting and credible body of data documenting misfolding of non-mutant SOD1 in ALS, typically demonstrated using antibodies particular for misfolded SOD1. These studies glance at the hypothesis that SOD1 may exhibit a convergence point in ALS, driving pathology ~ the agency of misfolding even if not mutated. Further, these reports hold been used to support the view that both wild type and mutant SOD1 be able to adopt a prion-like behavior, self-assembling to fashion toxic aggregates that can propagate greater quantity misfolding.

“What I have not seen extensively wilful yet is misfolding of SOD1 in other neurodegenerative disorders. This study would heave in sight to show that misfolding of savage-type SOD1 is not specific. And, whether it is not specific to ALS single might envision two opposite extremes of sense (and there are probably many others).

“Perhaps misfolding of frenzied-type SOD1 is neurotoxic and drives pathogenesis in many neurodegenerative diseases, linking ALS, PD and it may be other disorders as a common, ailment-triggering, miscreant protein. At the other extreme point of the spectrum, does this study recommend that misfolding of wild-type SOD1 is simply a byproduct pathology in a dissolution neuron, which is completely unrelated to causing complaint?”

David Sulzer, MD, professor of psychiatry, neurology and pharmacology at Columbia University Medical Center, agrees through this idea. “When you enter upon to aggregate one type of protein, the identical type of aggregation may occur through other proteins. Maybe there is a convergence in these processes that lead to aggregation in neurodegenerative disorders.”

“There seems to be a serious problem with copper dysregulation in the unnatural region in PD,” said Ashley Bush, MD, PhD, professor of neuroscience at the Florey Institute with a view to Neuroscience and Mental Health at the University of Melbourne, who has worn out his career studying the role of metals in neurodegenerative diseases.

“We be favored with looked at this too. We institute that this may contribute to lowered nigral ceruloplasmin mode of action, which, in turn, can cause toxic iron collection. It’s a domino effect.”

21 July 2016 – Volume 16 – Issue 14 – p 31

doi: 10.1097/01.NT.0000490354.26741.b3

Normal 0 feigned false false EN-US JA X-NONE

http://journals.lww.com/neurotodayonline/Fulltext/2016/07210/News_from_the_International_Congress_of.9.aspx

I deep-read this my fear of the blindness immediately went away.

Both comments and pings are currently closed.